Abstract:The results documented impairment of central nociceptive inhibition processing in BMS patients which was more extensive in central BMS than peripheral BMS. Aim To evaluate conditioned pain modulation (CPM) in burning mouth syndrome (BMS) patients with different pain mechanisms. Materials and Methods Twenty BMS patients (52.0 ± 6.8 years, 17 women and 3 men) and age‐ and gender‐matched 22 healthy controls were enrolled in this randomised controlled trial. The patients received an active lingual nerve block (lidocaine) and a placebo injection (saline) randomly with an interval of 1 week in a double‐blinded manner. Patients evaluated their pain intensity on a 0‐ to 10‐cm visual analogue scale (VAS) before and after each injection, with or without CPM. Based on the anaesthesia effect, BMS patients were divided into two groups with presumed different pain mechanisms; a 'central subgroup (n = 11)' with pain relief less than 1 cm and 'peripheral subgroup (n = 9)' with pain relief more than 1 cm on the VAS. Mechanical pain threshold (MPT) and wind‐up ratio (WUR) were investigated at two oral mucosa regions: the region with most intense symptoms and a control region for the patient group; tongue and buccal region for the control group. CPM was induced by immersing the left hand into cold water. A moderate level of pain (around five on the VAS) was obtained by adjusting the water temperature. MPT and WUR were measured twice for all the participants with and without CPM, which was analysed and presented as relative change in MPT and WUR. Differences between groups were analysed using two‐way ANOVA. Differences within group between tests were assessed by paired t‐test. Results At baseline, there were no significant group differences for MPT or WUR between BMS patients and healthy controls (p ≥ 0.156). The mean bath temperature to evoke moderate pain for the BMS group was significantly lower than that for the healthy control group (8.9°C vs. 11.9°C, p = 0.003). The CPM evoked an inhibitory modulation in 18.2%–44.4% of BMS patients, while for the healthy group, the ratio was 68.2%–81.8%. Central BMS patients had smaller CPM effects than healthy participants at the painful site and control site, which indicated a decreased CPM function (p ≤ 0.034). Peripheral BMS patients had lower CPM effects than healthy participants only at the painful site (p = 0.037). Conclusions The present findings documented impairment of central nociceptive inhibition processing in BMS patients which was more extensive in central BMS than peripheral BMS. These findings add to the suggestion that BMS may a heterogeneous pain condition with at least two different phenotypes.

Recent advances in the understanding of the aetiology and therapeutic strategies in burning mouth syndrome: Focus on the actions of cannabinoids

Current advances in research of burning mouth syndrome: biological nerve and social psychology patterns

Advances in comprehensive multidisciplinary treatment for burning mouth syndrome

Burning mouth syndrome: current clinical, physiopathologic, and therapeutic data

Structural and Functional Connectivity Between the Amygdala and Orbital Frontal Cortex in Burning Mouth Syndrome: An fMRI Study

Local anesthesia nerve block for managing burning mouth syndrome: a scoping review

The improvement of pain symptoms in patients with burning mouth syndrome through combined laser and medication therapy

A review of animal models for burning mouth syndrome: Mechanistic insights and knowledge gaps

Different therapeutic strategies for burning mouth syndrome: preliminary data

Mesoporous Silica Particles As a Multifunctional Delivery System for Pain Relief in Experimental Neuropathy.

Topical amitriptyline in burning mouth syndrome: A retrospective real-world evidence study

Distinctive salivary oral microbiome in patients with burning mouth syndrome depending on pain intensity compared to healthy subjects

A Systematic Review of Acupuncture or Acupoint Injection for Management of Burning Mouth Syndrome.

Challenge in the diagnosis, evaluation, and management of burning mouth sensation: A retrospective cohort study

Proteomic profiling of whole-saliva reveals correlation between Burning Mouth Syndrome and the neurotrophin signaling pathway

Photobiomodulation Therapy For Burning Mouth Syndrome Management: A Randomized Double-Blind Controlled Trial.

Evaluation of peripheral nerve fibers and mast cells in burning mouth syndrome

Conditioned Pain Modulation Differences in Central and Peripheral Burning Mouth Syndrome (BMS) Patients

Saliva and tongue microbiota in burning mouth syndrome: An exploratory study of potential roles

Burning mouth in oncology care: a systematic review

Clinical effect of auricular point therapy on burning mouth syndrome